Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer
Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer
Recruiting · NCT06768931 · Registry updated 2026-04-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 2 | 2026-04-01 | NCT06768931 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sun Yat-sen University | 606 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Central Hospital of Guangdong Nongken | Zhanjiang | China | 1 |
| Dongguan People's Hospital | Dongguan | China | 8 |
| Gansu Cancer Hospital | Lanzhou | China | 6 |
| Sun Yat Sen University Cancer Center | Guangzhou | China | 15 |
| Zigong Fourth People's Hospital | Zigong | China | 2 |